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Background
Published guidelines recommend HIV genotype resis-
tance testing for all pregnant women with detectable
viraemia, regardless of antiretroviral therapy (ART)
exposure, enabling to optimize ART.
Objectives:
To identify different HIV subtypes in pregnant women
and correlate them with epidemiological factors.
Methods
HIV genotype resistance tests results were available on
50 HIV-infected pregnant women between 2003 and
2010.
Results
T h er e s u l t ss h o w e dam a j o r i t yo fc a s e so fn o n - Bs u b -
types: subtype G 42%, subtype B 24%, subtype C 14%,
C R F 0 2 _ A G1 2 % ,s u b t y p e sA ,D ,C R F O 3 _ B Ga n d
CRF01_AE 2%. Comparative study of the different sub-
types showed epidemiological differences:
￿Subtype G: 81,6% of women of Portuguese origin,
14,4% of African origin, with 76% of infection acquired
by sexual transmission and 23,8% by intravenous drug
use, 28,6% of women were on ART, and the median
time of HIV infection was three and a half years.
￿Subtype B: all of the women of Portuguese origin,
with 83,3% of infection acquired by sexual transmission
and 16,78% by intravenous drug use, 50% of women
were on ART, and the median time of HIV infection
was eight years.
￿Subtype C: all of the women of African origin, all
acquired the infection by sexual transmission, none of
the women were on ART, and the median time of HIV
infection was three years.
￿CRF02_AG: 63,2% of women of Portuguese origin,
28,6% of African origin, with 57,1% of infection acquired
by sexual transmission, 28,6% by intravenous drug use,
and 14,3% by vertical transmission, 14,3% of women
were on ART, and the median time of HIV infection
was 2 years.
Conclusions
The analysis of this data shows a bimodal distribution of
the epidemic in Portugal: an initial epidemic with B
strains, as in western Europe, and a second, latter one,
with non-B subtypes, disseminated through patients
from African origin and intravenous drug users. The
presence on non-B strains, with intrinsic patterns of
resistance, puts a burden on the management of these
women.
Published: 8 November 2010
doi:10.1186/1758-2652-13-S4-P145
Cite this article as: Afonso et al.: Genotype testing in HIV-infected
pregnant women. Journal of the International AIDS Society 2010 13(Suppl
4):P145.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Hospital de Santa Maria, Infectious Diseases, Lisbon, Portugal
Afonso et al. Journal of the International AIDS Society 2010, 13(Suppl 4):P145
http://www.jiasociety.org/content/13/S4/P145
© 2010 Afonso et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.